Overview
This course covers the use of buprenorphine extended-release (known as bup-XR, which is an injection) to treat opioid use disorder. It describes the process of initiating a patient on the medication, as well as how to manage missed doses, acute pain and other clinical scenarios, and it includes a case study. It should take 1-1.5 hours to complete.
Audience
This is for clinicians who are already prescribing, dispensing and administering the sublingual form of buprenorphine-naloxone (bup-nlx) medication.
For health care workers who are unfamiliar with buprenorphine medications, we recommend the course titled, Buprenorphine Treatment for Opioid Use Disorder, which covers the fundamentals of both forms of the medication (sublingual and injected).
Learning objectives
- Describe the pharmacokinetic and pharmacodynamic properties of the long-acting buprenorphine formulation
- Compare available buprenorphine formulations, dosage and indications.
- Describe plans for induction, titration, missed doses and tapering of bup-XR.
- Review the clinical efficacy and safety of bup-XR by examining clinical trial data.
- Evaluate stakeholder perspectives on bup-XR.
- Plan how to introduce bup-XR into your clinical practice.
Delivery Method
This is an online, self-paced course.
Please note: This course requires you to use an internet browser, but the system does not support Microsoft Internet Explorer. Do not use that to access the course. Instead, use one of the following:
- Apple Safari
- Google Chrome
- Microsoft Edge
- Mozilla Firefox
For more details, please read the browser and compatibility support page.
Please review the cancellation policy.
Certification and accreditation
• College of Family Physicians of Canada: 1.5 Mainpro+ credits (Program ID# 202155-001)
• Royal College of Physicians and Surgeons: 1.5 Section 1 hours
Affiliations and partnerships
The continuing education event has been designated a University of Toronto accredited event.
